REDDING,
Calif., July 16, 2024 /PRNewswire/
-- According to a new market research report titled,
'Autoimmune Disease Diagnostics Market Size,
Share, Forecast, & Trends Analysis By Product (Reagents, Kits,
Assays, Instruments), Test Type (ANA, CRP, ESR, Rheumatoid Factor,
Routine Test), Disease Type (Systemic, Localized) - Global Forecast
to 2031,' published by Meticulous Research®,
the Autoimmune Disease Diagnostics Market is projected to reach
$10.55 billion by 2031, at a
CAGR of 7.2% from 2024 to 2031.
Download Sample Report Now-
https://www.meticulousresearch.com/download-sample-report/cp_id=5405
Various tests such as antinuclear antibodies (ANA), C-reactive
protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid
factor, immunoglobulins, and routine blood tests can be done to
diagnose and monitor autoimmune diseases. These tests detect
systemic autoimmune diseases affecting multiple organs or systems
or specific autoimmune diseases. The increasing prevalence of
autoimmune disorders, the growing emphasis on early diagnosis, and
the rising awareness regarding autoimmune diseases are some of the
major drivers for the growth of this market.
Increasing Investments & Funding in the Autoimmune
Diseases Space Generating Market Growth Opportunities
Research plays a vital role in developing diagnostic and
therapeutic technologies for autoimmune disease diagnosis and
monitoring. Research also helps increase medical professionals'
understanding of these diseases. Celiac disease is one of the most
common autoimmune diseases globally. Increasing funding and
investments for research on autoimmune diseases are expected to
generate growth opportunities for the players operating in this
market. For instance, according to the National Institutes of
Health (NIH) (U.S.), in 2021, research spending for celiac disease
reached USD 9 million. Moreover, in
2021, the National Health and Medical Research Council (NHMRC)
(Australia), a government entity,
awarded USD 1.1 million to a
researcher to carry out research activities to understand the
symptoms of the disease and improve health outcomes related to the
diseases.
Sufficient financial support in the form of funding and
investments enables diagnostic companies and research institutions
to focus on developing cutting-edge and progressive diagnostic
technologies with enhanced precision, sensitivity, and specificity
and exploring novel biomarkers and diagnostic
instruments.
Get a Glimpse Inside: Request Sample Pages-
https://www.meticulousresearch.com/request-sample-report/cp_id=5405
The key players operating in the autoimmune disease diagnostics
market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad
Laboratories, Inc. (U.S.), Beckman
Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Becton,
Dickinson, and Company (U.S.), PerkinElmer, Inc. (U.S.), F.
Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG
(Germany), Grifols, S.A.
(Spain), and Creative Diagnostics
(U.S.).
The autoimmune disease diagnostics market is segmented by
product type (reagents, kits, & assays, instruments, software
& services), test type (antinuclear antibody test, c-reactive
protein test, Erythrocyte Sedimentation Rate Test, rheumatoid
factor test, immunoglobulins test, routine blood tests, and other
autoimmune tests), disease type (systemic autoimmune diseases
{rheumatoid arthritis, psoriasis, systemic lupus erythematosus,
multiple sclerosis, and other systemic autoimmune diseases},
organ-specific autoimmune diseases {Type-1 diabetes, celiac
disease, inflammatory bowel disease, other organ-specific
autoimmune diseases}), end user (diagnostic laboratories, clinics
& hospitals, and academic & research institutes), and
geography. The study also evaluates industry competitors and
analyzes their market shares at the global and regional levels.
Based on product type, the autoimmune disease diagnostics market
is segmented into reagents, assays, & kits and instruments. In
2024, the reagents, kits, & assays segment is expected to
account for the largest share of 84.0% the autoimmune
disease diagnostics market. The large market share of this segment
is attributed to factors such as the recurrent use of reagents,
assays, & kits; the availability of antibodies and other
reagents for several test applications; and the increasing number
of launches & approvals of consumables.
Have Specific Research Needs? Request a Customized
Report-
https://www.meticulousresearch.com/request-customization/cp_id=5405
Based on test type, the autoimmune disease diagnostics market is
segmented into antinuclear antibodies test (ANA), C-reactive
protein test (CRP), erythrocyte sedimentation rate test, rheumatoid
factor test, immunoglobulins test, routine blood tests, and other
test types. In 2024, the antinuclear antibodies (ANA) segment is
expected to account for the largest share of 29.4% of the
autoimmune disease diagnostics market. Antinuclear antibody tests
look for autoantibodies in blood, which attack one's healthy cells.
Antibodies are formed in the blood much earlier than the onset of
the actual disease in an individual. This enables the early
diagnosis of the disease, which helps to reduce morbidity and
mortality due to the disease. Thus, the high prevalence of
autoimmune diseases and the need for early diagnosis of autoimmune
diseases are the factors responsible for the large market share of
this segment.
Based on end user, the autoimmune disease diagnostics market is
segmented into hospitals & clinics, diagnostic laboratories,
and academic & research institutes. In 2024, the diagnostic
laboratories segment is expected to account for the largest share
of the market. Diagnostic laboratories receive samples from various
healthcare centers, including hospitals and clinics. Diagnostics
laboratories are crucial in providing accurate diagnostic results
and managing disease management. Diagnostic laboratories process
more samples in less time due to the well-equipped systems and the
presence of skilled professionals. These factors contribute to the
large market share of this segment in the autoimmune diseases
diagnostics market.
Based on geography, in 2024, North
America is expected to account for the largest share of
39.6% of the global autoimmune disease diagnostics market.
However, Asia-Pacific is slated to
register the highest growth rate during the forecast period. The
high market growth in Asia-Pacific
is attributed to the growing prevalence and incidence of celiac
diseases & rheumatoid arthritis, unhealthy lifestyles,
government initiatives concerning autoimmune diseases, and
increasing expenditure on the research of autoimmune diseases.
There is a growing prevalence of autoimmune disease in the
Asia-Pacific region. For instance,
psoriasis, an autoimmune disease, is one of the most common skin
conditions globally. According to the Global Psoriasis Atlas,
around 3.59 million people in India have psoriasis, which is expected to
increase.
The report also includes an extensive assessment of the key
growth strategies adopted by major market players between
2021 and 2024. The autoimmune disease diagnostics market has
witnessed several product launches, collaborations, agreements, and
expansions in the past few years.
Browse In-depth Report Now-
https://www.meticulousresearch.com/product/autoimmune-disease-diagnostics-market-5405
Scope of the Report:
Autoimmune Disease Diagnostics Market, by Product
Type
- Reagents, Assays, and Kits
- Instruments
- Software & Services
Autoimmune Disease Diagnostics Market, by Test Type
- Antinuclear Antibodies (ANA) Test
- Rheumatoid Factor Test
- Immunoglobulins Test
- Routine Blood Tests Test
- C-reactive Protein (CRP) Test
- Erythrocyte Sedimentation Rate (ESR) Test
- Other Test Types
(Note: Other test types include Anti-double stranded DNA,
Extractable nuclear antigen, Anti-signal recognition particle
tests, Ferritin, and Anti-cyclic Citrullinated Peptide (Anti-CCP)
Antibodies)
Autoimmune Disease Diagnostics Market, by Disease
Type
- Systemic Autoimmune Diseases
- Rheumatoid Arthritis
- Psoriasis
- Systemic Lupus Erythematosus
- Multiple Sclerosis
- Other Systemic Autoimmune Diseases
(Other systemic autoimmune diseases include systemic scleroderma,
dermatomyositis, Sjögren's syndrome, mixed connective tissue
disease, Behçet syndrome, sarcoidosis, and myasthenia gravies,
among others.)
- Organ-specific Autoimmune Diseases
- Type-1 Diabetes
- Celiac Diseases
- Inflammatory Bowel Disease
- Other Organ-Specific Diseases
(Other organ-specific autoimmune diseases include Addison's
disease, Grave's disease, Guillain-Barre syndrome, Hashimoto's
thyroiditis, and Sclerosing cholangitis, among others.)
Autoimmune Disease Diagnostics Market, by End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
Autoimmune Disease Diagnostics Market, by Geography
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Unlock Opportunities: Buy Now-
https://www.meticulousresearch.com/Checkout/43796696
Related Reports:
In Vitro Diagnostic (IVD) Reagents Market by Type
(Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology
(Immunoassay, Hematology, Microbiology), Use (Research, Analyte
Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory)
- Global Forecast to 2027
In-vitro Diagnostics Market by Offering (Kits,
Software), Technology (Immunoassay, Molecular Diagnostics [PCR,
NGS, Microarray], Rapid Tests, Biochemistry), Application
(Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) -
Global Forecast to 2030
Molecular Diagnostics Market by Product (Reagent &
Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR,
ISH, INAAT, Sequencing, Microarray), Application (Infectious
Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Global
Forecast to 2030
About Meticulous Research®
Meticulous Research® was founded in 2010 and
incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a
private limited company under the Companies Act, 1956. Since its
incorporation, the company has become the leading provider of
premium market intelligence in North
America, Europe,
Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and
values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research
techniques, we have built strong capabilities in data collection,
interpretation, and analysis of data including qualitative and
quantitative research with the finest team of analysts. We design
our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research,
and consulting solutions to address business challenges of
sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn-
https://www.linkedin.com/company/meticulous-research
Content Source:
https://www.meticulousresearch.com/pressrelease/633/autoimmune-disease-diagnostics-market-2031
Logo:
https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original
content:https://www.prnewswire.com/news-releases/autoimmune-disease-diagnostics-market-to-be-worth-10-55-billion-by-2031---exclusive-report-by-meticulous-research-302197909.html
SOURCE Meticulous Market Research Pvt. Ltd.